Episode 179: Horizons in Haematology: Insights from the EHA President
Jonathan is joined by António Almeida, President of the European Hematology Association (EHA); and Professor and Director of the Clinical Haematology Service, Hospital da Luz, Lisbon, Portugal, to discuss his highlights since becoming EHA President. The pair cover the three pillars of EHA, the anticipated topics for the 2024 congress, and how Almeida has implemented a brand-new medical school, as well as much more.
Use the following timestamps to navigate the content in this episode:
(00.00)-Introduction
(01:55)-Almeida’s new medical school
(03:35)-EHA Master Class peer-based learning and modern medical education
(09:00)-Presidential highlights
(11:50)-EHA’s three pillars in the coming year
(16:05)-EHA 2024 in Madrid
(20:15)-Research in myeloproliferative and myelodysplastic syndromes
(23:00)-Clinical trial updates in myelodysplastic syndromes and chronic myeloid leukaemia
(26:50)-Changes over the course of Almeida’s career
(31:30)-Treatment advances on the horizon
(32:50)-CRISPR to treat sickle cell disease and β-thalassaemia
(36:30)-Three wishes for the future of healthcare
Create your
podcast in
minutes
It is Free